Status:
COMPLETED
Pharmacovigilance and Patient Compliance in Hypertensive Patients
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Study to confirm the safety profile of telmisartan (benefit-risk ratio) under normal conditions of use after market launch and to supplement the present data on the safety of telmisartan. Furthermore ...
Eligibility Criteria
Inclusion
- \- Patients of either sex over the age of 18 years suffering from non-secondary essential hypertension with values of at least 90 mmHg (diastolic) and 140 mmHg (systolic)
Exclusion
- \- corresponding to the contraindications listed in the summary of product characteristics of the drug
Key Trial Info
Start Date :
May 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
10333 Patients enrolled
Trial Details
Trial ID
NCT02200575
Start Date
May 1 1999
Last Update
July 25 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.